Interestingly, the BAT was used in a recent study to monitor tolerance induction in children who underwent oral immunotherapy with egg [26], and basophil histamine release has been used to monitor the effectiveness of anti-IgE (omalizumab) treatment administered prior to an oral immunotherapy regime in patients with severe peanut allergy [27]. Here, IGHE is linked to peanut allergic reaction.